Prion-like Properties of Pathological TDP-43 Aggregates from Diseased Brains

Cell Reports - Tập 4 Số 1 - Trang 124-134 - 2013
Takashi Nonaka1, Masami Masuda‐Suzukake1, Tetsuaki Arai2, Yoko Hasegawa1, Hiroyasu Akatsu3, Tomokazu Obi4, Mari Yoshida5, Shigeo Murayama6, David Mann7, Haruhiko Akiyama2, Masato Hasegawa1
1Department of Neuropathology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Setagaya-ku, Tokyo 156-8506, Japan
2Dementia Research Project, Tokyo Metropolitan Institute of Medical Science, Setagaya-ku, Tokyo 156-8506, Japan
3Choju Medical Institute, Fukushimura Hospital, Toyohashi, Aichi 441-8124, Japan
4Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka, Shizuoka 420-8688, Japan
5Institute for Medical Science of Aging, Aichi Medical University, Nagakute, Aichi 480-1195, Japan
6Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Itabashi-ku, Tokyo 173-0015, Japan,
7Centre for Clinical and Cognitive Neuroscience, Institute of Brain Behavior and Mental Health, University of Manchester, Salford M6 8HD, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Arai, 2006, TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Biochem. Biophys. Res. Commun., 351, 602, 10.1016/j.bbrc.2006.10.093

Arai, 2010, Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy, Neuropathology, 30, 170, 10.1111/j.1440-1789.2009.01089.x

Bence, 2001, Impairment of the ubiquitin-proteasome system by protein aggregation, Science, 292, 1552, 10.1126/science.292.5521.1552

Bigio, 2013, Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid, Acta Neuropathol., 125, 463, 10.1007/s00401-013-1089-6

Braak, 1991, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol., 82, 239, 10.1007/BF00308809

Braak, 2003, Staging of brain pathology related to sporadic Parkinson’s disease, Neurobiol. Aging, 24, 197, 10.1016/S0197-4580(02)00065-9

Brooks, 1994, J. Neurol. Sci., 124, 96, 10.1016/0022-510X(94)90191-0

Budini, 2012, Cellular model of TAR DNA binding protein 43 (TDP-43) aggregation based on its C-terminal Q/N rich region, J. Biol. Chem., 287, 7512, 10.1074/jbc.M111.288720

Buratti, 2009, The molecular links between TDP-43 dysfunction and neurodegeneration, Adv. Genet., 66, 1, 10.1016/S0065-2660(09)66001-6

Buratti, 2001, Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping, EMBO J., 20, 1774, 10.1093/emboj/20.7.1774

Clavaguera, 2009, Transmission and spreading of tauopathy in transgenic mouse brain, Nat. Cell Biol., 11, 909, 10.1038/ncb1901

de Calignon, 2012, Propagation of tau pathology in a model of early Alzheimer’s disease, Neuron, 73, 685, 10.1016/j.neuron.2011.11.033

Desplats, 2009, Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein, Proc. Natl. Acad. Sci. USA, 106, 13010, 10.1073/pnas.0903691106

Fevrier, 2004, Cells release prions in association with exosomes, Proc. Natl. Acad. Sci. USA, 101, 9683, 10.1073/pnas.0308413101

Frost, 2009, Propagation of tau misfolding from the outside to the inside of a cell, J. Biol. Chem., 284, 12845, 10.1074/jbc.M808759200

Furukawa, 2011, A seeding reaction recapitulates intracellular formation of Sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions, J. Biol. Chem., 286, 18664, 10.1074/jbc.M111.231209

Goedert, 2010, The propagation of prion-like protein inclusions in neurodegenerative diseases, Trends Neurosci., 33, 317, 10.1016/j.tins.2010.04.003

Gousset, 2009, Prions hijack tunnelling nanotubes for intercellular spread, Nat. Cell Biol., 11, 328, 10.1038/ncb1841

Guo, 2011, An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity, Nat. Struct. Mol. Biol., 18, 822, 10.1038/nsmb.2053

Hasegawa, 2008, Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Ann. Neurol., 64, 60, 10.1002/ana.21425

Hasegawa, 2011, Molecular dissection of TDP-43 proteinopathies, J. Mol. Neurosci., 45, 480, 10.1007/s12031-011-9571-x

Igaz, 2009, Expression of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 proteinopathies, J. Biol. Chem., 284, 8516, 10.1074/jbc.M809462200

Kordower, 2008, Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson’s disease, Nat. Med., 14, 504, 10.1038/nm1747

Li, 2008, Lewy bodies in grafted neurons in subjects with Parkinson’s disease suggest host-to-graft disease propagation, Nat. Med., 14, 501, 10.1038/nm1746

Liu, 2012, Trans-synaptic spread of tau pathology in vivo, PLoS ONE, 7, e31302, 10.1371/journal.pone.0031302

Luk, 2009, Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells, Proc. Natl. Acad. Sci. USA, 106, 20051, 10.1073/pnas.0908005106

Luk, 2012, Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice, Science, 338, 949, 10.1126/science.1227157

Luk, 2012, Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice, J. Exp. Med., 209, 975, 10.1084/jem.20112457

Mackenzie, 2011, A harmonized classification system for FTLD-TDP pathology, Acta Neuropathol., 122, 111, 10.1007/s00401-011-0845-8

Masuda-Suzukake, 2013, Prion-like spreading of pathological α-synuclein in brain, Brain, 136, 1128, 10.1093/brain/awt037

Neary, 1998, Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria, Neurology, 51, 1546, 10.1212/WNL.51.6.1546

Neumann, 2006, Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Science, 314, 130, 10.1126/science.1134108

Nonaka, 2009, A cellular model to monitor proteasome dysfunction by alpha-synuclein, Biochemistry, 48, 8014, 10.1021/bi900619j

Nonaka, 2009, Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43, Hum. Mol. Genet., 18, 3353, 10.1093/hmg/ddp275

Nonaka, 2010, Seeded aggregation and toxicity of alpha-synuclein and tau: cellular models of neurodegenerative diseases, J. Biol. Chem., 285, 34885, 10.1074/jbc.M110.148460

Pesiridis, 2009, Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis, Hum. Mol. Genet., 18, R156, 10.1093/hmg/ddp303

Polymenidou, 2011, The seeds of neurodegeneration: prion-like spreading in ALS, Cell, 147, 498, 10.1016/j.cell.2011.10.011

Ren, 2009, Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates, Nat. Cell Biol., 11, 219, 10.1038/ncb1830

Sephton, 2010, TDP-43 is a developmentally regulated protein essential for early embryonic development, J. Biol. Chem., 285, 6826, 10.1074/jbc.M109.061846

Snowden, 2002, Frontotemporal dementia, Br. J. Psychiatry, 180, 140, 10.1192/bjp.180.2.140

Tsuji, 2012, Molecular analysis and biochemical classification of TDP-43 proteinopathy, Brain, 135, 3380, 10.1093/brain/aws230

Wu, 2010, TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis, Genesis, 48, 56, 10.1002/dvg.20584

Zhang, 2009, Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity, Proc. Natl. Acad. Sci. USA, 106, 7607, 10.1073/pnas.0900688106

Fujiwara, 2002, α-Synuclein is phosphorylated in synucleinopathy lesions, Nat. Cell Biol., 4, 160, 10.1038/ncb748

Inukai, 2008, Abnormal phosphorylation of Ser409/410 of TDP-43 in FTLD-U and ALS, FEBS Lett., 582, 2899, 10.1016/j.febslet.2008.07.027